Latest News
-
Senhwa Biosciences Silmitasertib Named as Potential Covid-19 Therapy
Mar 31, 2020 -
Senhwa’s Abstract of Silmitasertib for the Treatment of Basal Cell Carcinoma Clinical Trial Accepted for 2020 ASCO Online Publication
May 14, 2020